Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors

Clinical trial NCT03950609 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03950609
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Carcinoid Tumor Digestive System Neuroendocrine Neoplasm Multiple Endocrine Neoplasia Type 1 Neuroendocrine Neoplasm Unresectable Carcinoid Tumor

Start date: 2019-07-30
Primary completion: 2028-03-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.